ArticleJournal of cancer research and clinical oncology2020

Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series.

Christoph Oing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.